AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-99
Results: 1-25/99

Authors: TANI H OOURA T KAMIDATE T KAMATAKI T WATANABE H
Citation: H. Tani et al., SEPARATION OF MICROSOMAL CYTOCHROME B(5) VIA PHASE-SEPARATION IN A MIXED-SOLUTION OF TRITON X-114 AND CHARGED DEXTRAN, Journal of chromatography B. Biomedical sciences and applications, 708(1-2), 1998, pp. 294-298

Authors: SAWADA M KAMATAKI T
Citation: M. Sawada et T. Kamataki, GENETICALLY-ENGINEERED CELLS STABLY EXPRESSING CYTOCHROME-P450 AND THEIR APPLICATION TO MUTAGEN ASSAYS, Mutation research. Reviews in mutation research, 411(1), 1998, pp. 19-43

Authors: MORI T ITOH S KAMATAKI T
Citation: T. Mori et al., MOLECULAR-CLONING AND REGULATION OF A NOVEL GUINEA-PIG CYTOCHROME-P450 (CYP3A20) WHICH DIFFERS FROM GUINEA-PIG CYP3A14 IN ONLY 2 AMINO-ACID-RESIDUES, Biochemistry and molecular biology international, 44(6), 1998, pp. 1245-1253

Authors: ANDO Y CHIDA M NAKAYAMA K SAKA H KAMATAKI T
Citation: Y. Ando et al., THE UGT1A1-ASTERISK-28 ALLELE IS RELATIVELY RARE IN A JAPANESE POPULATION, Pharmacogenetics, 8(4), 1998, pp. 357-360

Authors: NUNOYA K YOKOI T KIMURA K INOUE K KODAMA T FUNAYAMA M NAGASHIMA K FUNAE Y GREEN C KINOSHITA M KAMATAKI T
Citation: K. Nunoya et al., A NEW DELETED ALLELE IN THE HUMAN CYTOCHROME-P450 2A6 (CYP2A6) GENE FOUND IN INDIVIDUALS SHOWING POOR METABOLIC CAPACITY TO COUMARIN AND (-CIS-3,5-DIMETHYL-2-(3-PYRIDYL)THIAZOLIDIN-4-ONE HYDROCHLORIDE (SM-12502)()), Pharmacogenetics, 8(3), 1998, pp. 239-249

Authors: ANDO Y SAKA H ASAI G SUGIURA S SHIMOKATA K KAMATAKI T
Citation: Y. Ando et al., UGT1A1 GENOTYPES AND GLUCURONIDATION OF SN-38, THE ACTIVE METABOLITE OF IRINOTECAN, Annals of oncology, 9(8), 1998, pp. 845-847

Authors: YOKOI T KAMATAKI T
Citation: T. Yokoi et T. Kamataki, GENETIC-POLYMORPHISM OF DRUG-METABOLIZING-ENZYMES - NEW MUTATIONS IN CYP2D6 AND CYP2A6 GENES IN JAPANESE, Pharmaceutical research, 15(4), 1998, pp. 517-524

Authors: KAMATAKI T YOKOI T FUJITA K ANDO Y
Citation: T. Kamataki et al., PRECLINICAL APPROACH FOR IDENTIFYING DRUG-INTERACTIONS, Cancer chemotherapy and pharmacology, 42, 1998, pp. 50-53

Authors: TAKASUNA K HAGIWARA T HIROHASHI M KATO M NOMURA M NAGAI E YOKOI T KAMATAKI T
Citation: K. Takasuna et al., INHIBITION OF INTESTINAL MICROFLORA BETA-GLUCURONIDASE MODIFIES THE DISTRIBUTION OF THE ACTIVE METABOLITE OF THE ANTITUMOR AGENT, IRINOTECAN HYDROCHLORIDE (CPT-11) IN RATS, Cancer chemotherapy and pharmacology, 42(4), 1998, pp. 280-286

Authors: NAKAMURA K YOKOI T KODAMA T INOUE K NAGASHIMA K SHIMADA N SHIMIZU T KAMATAKI T
Citation: K. Nakamura et al., OXIDATION OF HISTAMINE H1 ANTAGONIST MEQUITAZINE IS CATALYZED BY CYTOCHROME-P450 2D6 IN HUMAN LIVER-MICROSOMES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 435-435

Authors: TAKASUNA K HAGIWARA T KAMATAKI T
Citation: K. Takasuna et al., INVOLVEMENT OF BETA-GLYCURONIDASE IN INTESTINAL MICROFLORA IN THE INTESTINAL TOXICITY OF THE ANTITUMOR CAMPTOTHECIN DERIVATIVE, IRINOTECAN (CPT-11), IN RATS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 5434-5434

Authors: NAKAMURA K YOKOI T KODAMA T INOUE K NAGASHIMA K SHIMADA N SHIMIZU T KAMATAKI T
Citation: K. Nakamura et al., OXIDATION OF HISTAMINE H1 ANTAGONIST MEQUITAZINE IS CATALYZED BY CYTOCHROME-P450 2D6 IN HUMAN LIVER-MICROSOMES, The Journal of pharmacology and experimental therapeutics, 284(2), 1998, pp. 437-442

Authors: TASAKI T NAKAMURA A ITOH S OHASHI K YAMAMOTO Y MASUDA M IWATA H KAZUSAKA A KAMATAKI T FUJITA S
Citation: T. Tasaki et al., EXPRESSION AND CHARACTERIZATION OF DOG CYP2D15 USING BACULOVIRUS EXPRESSION SYSTEM, Journal of Biochemistry, 123(1), 1998, pp. 162-168

Authors: SUZUKI A KUSHIDA H IWATA H WATANABE M NOHMI T FUJITA K GONZALEZ FJ KAMATAKI T
Citation: A. Suzuki et al., ESTABLISHMENT OF A SALMONELLA TESTER STRAIN HIGHLY SENSITIVE TO MUTAGENIC HETEROCYCLIC AMINES, Cancer research, 58(9), 1998, pp. 1833-1838

Authors: ANDO Y SHIMIZU T NAKAMURA K MUSHIRODA T NAKAGAWA T KODAMA T KAMATAKI T
Citation: Y. Ando et al., POTENT AND NONSPECIFIC INHIBITION OF CYTOCHROME-P450 BY JM216, A NEW ORAL PLATINUM AGENT, British Journal of Cancer, 78(9), 1998, pp. 1170-1174

Authors: SAKUMA T HIEDA M IGARASHI T OHGIYA S NAGATA R NEMOTO N KAMATAKI T
Citation: T. Sakuma et al., MOLECULAR-CLONING AND FUNCTIONAL-ANALYSIS OF CYNOMOLGUS MONKEY CYP1A2, Biochemical pharmacology, 56(1), 1998, pp. 131-139

Authors: IWATA H FUJITA K KUSHIDA H SUZUKI A KONNO Y NAKAMURA K FUJINO A KAMATAKI T
Citation: H. Iwata et al., HIGH CATALYTIC ACTIVITY OF HUMAN CYTOCHROME-P450 COEXPRESSED WITH HUMAN NADPH-CYTOCHROME P450 REDUCTASE IN ESCHERICHIA-COLI, Biochemical pharmacology, 55(8), 1998, pp. 1315-1325

Authors: YAMADA A FUJITA K YOKOI T MUTO S SUZUKI A GONDO Y KATSUKI M KAMATAKI T
Citation: A. Yamada et al., IN-VIVO DETECTION OF MUTATIONS INDUCED BY AFLATOXIN B-1 USING HUMAN CYP3A7 HITEC HYBRID MICE/, Biochemical and biophysical research communications (Print), 250(1), 1998, pp. 150-153

Authors: TAKAHASHI Y SUZUKI C KAMATAKI T
Citation: Y. Takahashi et al., SILENCING OF CYP1A1 EXPRESSION IN RABBITS BY DNA METHYLATION, Biochemical and biophysical research communications, 247(2), 1998, pp. 383-386

Authors: NAKURA H ITOH S KUSANO H ISHIZONE H KAMATAKI T
Citation: H. Nakura et al., OPPOSITE EFFECTS OF ISONIAZID AND FASTING ON THE EXPRESSION OF CYP2E1PROTEIN AND MESSENGER-RNA IN-HOUSE MUSK SHREW (SUNCUS-MURINUS), Biochemistry and molecular biology international, 41(2), 1997, pp. 293-301

Authors: TANI H SAITOH T KAMIDATE T KAMATAKI T WATANABE H
Citation: H. Tani et al., SELECTIVE SOLUBILIZATION OF MICROSOMAL ELECTRON-TRANSFER PROTEINS WITH ALKYLGLUCOSIDE, Analytical sciences, 13(5), 1997, pp. 747-751

Authors: FUJITA K IWATA H KUSHIDA H SUZUKI A NAKAMURA K KONNO Y KAMATAKI T
Citation: K. Fujita et al., SIMULTANEOUS EXPRESSION OF HUMAN P450 AND HUMAN NADPH-P450 REDUCTASE IN ESCHERICHIA-COLI - EXTREMELY HIGH-ACTIVITY TO METABOLIZE DRUGS, The FASEB journal, 11(9), 1997, pp. 119-119

Authors: GILLAM EMJ WUNSCH RM UENG YF SHIMADA T PARIKH A KAMATAKI T GUENGERICH FP
Citation: Emj. Gillam et al., EXPRESSION OF P450 3A7 IN ESCHERICHIA-COLI - EFFECTS OF 5 MODIFICATION AND CATALYTIC CHARACTERIZATION OF THE RECOMBINANT ENZYME, The FASEB journal, 11(9), 1997, pp. 144-144

Authors: NAKAYAMA K SUDO Y SASAKI Y IWATA H KAMATAKI T
Citation: K. Nakayama et al., TRANSCRIPTIONAL REGULATION OF CYP3A16 GENE - ANALYSIS BY DIRECT-INJECTION OF DNA INTO MOUSE-LIVER, The FASEB journal, 11(9), 1997, pp. 272-272

Authors: TAKAHASHI Y NAKAYAMA K FUJIIKURIYAMA Y KAMATAKI T
Citation: Y. Takahashi et al., NEGATIVE REGULATORS OF CYP1A1 EXPRESSION IN THE LIVER FROM ADULT-RABBITS, The FASEB journal, 11(9), 1997, pp. 292-292
Risultati: 1-25 | 26-50 | 51-75 | 76-99